However, there are many factors such as age, cancer type, timing and the type of treatment regimen, etc., to consider.In 2013, the Practice Committees for both American Society for Reproductive Medicine (ASRM) and Society for Assisted Reproductive Technology (SART) updated the guideline for cryopreservation of mature oocyte.